This list was compiled by Christine R. Isaacs, MD; and William M. Leininger, MD, as a supplement to their presentation from the 2021 American College for Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting (ACSM), held virtually April 30-May 2.
We estimated that the likelihood of a defense verdict was essentially a 50/50 proposition.
Significant updates occurred in women’s health issues while the world was in survival mode.
Acute fatty liver of pregnancy (AFLP) is a rare but potentially fatal condition characterized by hepatic failure.
The monikers “new mother’s thumb” or “mother’s wrist” stem from the increased incidence of this disorder seen during the third trimester of pregnancy and in the first few months after delivery, especially if breastfeeding.
Intrahepatic cholestasis of pregnancy (ICP) occurs in the second and third trimesters of pregnancy and is characterized by pruritus and elevated serum bile acid concentrations.
The pandemic put all of us into survival mode. As the slow recovery begins, doctors have been able to bring to light other health topics from which attention was diverted during this time. That is the nature of this month’s cover story.
Attention and accountability are the 2 “A’s” that drive change. It’s true in medicine, business, even family. If it is not monitored, it is not regarded as important nor will change be affected.
Nearly a third of women in poor or fair health have been without health care during the COVID-19 pandemic. Even more worrisome, only half of uninsured women have been to an ob/gyn provider over the past 3 years.
The most significant finding is to watch for symptoms of VVC in women with T2D.
Genetic factors predictive of reproductive aging also are linked to vasomotor symptoms (VMS), indicative of VMS having a polygenic architecture, according to an analysis of the Study of Women’s Health Across the Nation (SWAN) Genomic Substudy.
Early and routine contraceptive counseling for all women of reproductive age with cardiovascular disease or cardiovascular risk factors is an essential component of comprehensive cardiovascular care, according to evidence-based recommendations of contraceptive options published in the Journal of the American College of Cardiology (JACC).
